Analysts Offer Predictions for Harrow, Inc.'s Q2 2024 Earnings (NASDAQ:HROW)

Harrow, Inc. (NASDAQ:HROW – Free Report) – B. Riley dropped their Q2 2024 earnings per share (EPS) estimates for Harrow in a research report issued to clients and investors on Tuesday, May 14th. B. Riley analyst M. Mamtani now expects that the company will earn ($0.25) per share for the quarter, down from their previous […]

Related Keywords

Markl Baum ,Craig Hallum ,Jump Financial ,Harrow Health Inc ,Nasdaq ,Rice Hall James Associates ,Harrow Inc ,Securities Exchange Commission ,Kennedy Capital Management ,Stifel Financial Corp ,Pharmaceuticals Inc ,Eton Pharmaceuticals Inc ,Surface Ophthalmics Inc ,Opaleye Management Inc ,Free Report ,Get Free Report ,Capital Management ,Financial Corp ,Rice Hall James ,Opaleye Management ,Exchange Commission ,Surface Ophthalmics ,Melt Pharmaceuticals ,Eton Pharmaceuticals ,Harrow Daily ,